Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Angiogenesis PET Tracer Uptake (68Ga-NODAGA-E[(cRGDyK)]₂) in Induced Myocardial Infarction and Stromal Cell Treatment in Minipigs.

Rasmussen T, Follin B, Kastrup J, Brandt-Larsen M, Madsen J, Emil Christensen T, Juhl M, Cohen S, Pharao Hammelev K, Holdflod Møller C, Peter Goetze J, Hasbak P, Kjær A.

Diagnostics (Basel). 2018 May 16;8(2). pii: E33. doi: 10.3390/diagnostics8020033.

2.

Safety, Dosimetry, and Tumor Detection Ability of 68Ga-NOTA-AE105: First-in-Human Study of a Novel Radioligand for uPAR PET Imaging.

Skovgaard D, Persson M, Brandt-Larsen M, Christensen C, Madsen J, Klausen TL, Holm S, Andersen FL, Loft A, Berthelsen AK, Pappot H, Brasso K, Kroman N, Højgaard L, Kjaer A.

J Nucl Med. 2017 Mar;58(3):379-386. doi: 10.2967/jnumed.116.178970. Epub 2016 Sep 8.

3.

Angiogenesis PET Tracer Uptake ((68)Ga-NODAGA-E[(cRGDyK)]₂) in Induced Myocardial Infarction in Minipigs.

Rasmussen T, Follin B, Kastrup J, Brandt-Larsen M, Madsen J, Emil Christensen T, Pharao Hammelev K, Hasbak P, Kjær A.

Diagnostics (Basel). 2016 Jun 17;6(2). pii: E26. doi: 10.3390/diagnostics6020026.

4.

First-in-human uPAR PET: Imaging of Cancer Aggressiveness.

Persson M, Skovgaard D, Brandt-Larsen M, Christensen C, Madsen J, Nielsen CH, Thurison T, Klausen TL, Holm S, Loft A, Berthelsen AK, Ploug M, Pappot H, Brasso K, Kroman N, Højgaard L, Kjaer A.

Theranostics. 2015 Sep 13;5(12):1303-16. doi: 10.7150/thno.12956. eCollection 2015.

5.

Urokinase-Type Plasminogen Activator Receptor as a Potential PET Biomarker in Glioblastoma.

Persson M, Nedergaard MK, Brandt-Larsen M, Skovgaard D, Jørgensen JT, Michaelsen SR, Madsen J, Lassen U, Poulsen HS, Kjaer A.

J Nucl Med. 2016 Feb;57(2):272-8. doi: 10.2967/jnumed.115.161703. Epub 2015 Oct 1.

6.

Familial risk for major depression is associated with lower striatal 5-HT₄ receptor binding.

Madsen K, Torstensen E, Holst KK, Haahr ME, Knorr U, Frokjaer VG, Brandt-Larsen M, Iversen P, Fisher PM, Knudsen GM.

Int J Neuropsychopharmacol. 2014 Oct 31;18(1). pii: pyu034. doi: 10.1093/ijnp/pyu034.

7.

uPAR targeted radionuclide therapy with (177)Lu-DOTA-AE105 inhibits dissemination of metastatic prostate cancer.

Persson M, Juhl K, Rasmussen P, Brandt-Larsen M, Madsen J, Ploug M, Kjaer A.

Mol Pharm. 2014 Aug 4;11(8):2796-806. doi: 10.1021/mp500177c. Epub 2014 Jul 1.

PMID:
24955765
8.

Comparison of two new angiogenesis PET tracers 68Ga-NODAGA-E[c(RGDyK)]2 and (64)Cu-NODAGA-E[c(RGDyK)]2; in vivo imaging studies in human xenograft tumors.

Oxboel J, Brandt-Larsen M, Schjoeth-Eskesen C, Myschetzky R, El-Ali HH, Madsen J, Kjaer A.

Nucl Med Biol. 2014 Mar;41(3):259-67. doi: 10.1016/j.nucmedbio.2013.12.003. Epub 2013 Dec 12.

9.

Use of cis-[18F]fluoro-proline for assessment of exercise-related collagen synthesis in musculoskeletal connective tissue.

Skovgaard D, Kjaer A, Heinemeier KM, Brandt-Larsen M, Madsen J, Kjaer M.

PLoS One. 2011 Feb 11;6(2):e16678. doi: 10.1371/journal.pone.0016678.

Supplemental Content

Loading ...
Support Center